SEC Form D · filed August 17, 2022
ACELRX PHARMACEUTICALS INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (32)
Jill P. Broadfoot · Hayward, CADirectorVincent J. Angotti · Hayward, CAExec · DirectorHoward B. Rosen · Hayward, CADirectorStephen J. Hoffman · Hayward, CADirectorMark B. Wan · Hayward, CADirectorMarina P. Bozilenko · Hayward, CADirectorRaffi P. Asadorian · Hayward, CAExecRichard P. Afable · Hayward, CADirectorPamela P. Palmer · Hayward, CAExec · DirectorAdrian P. Adams · Hayward, CADirectorBadri P. Dasu · Hayward, CAExecMichelle S. Riley · New York, NYDirectorSamuel Markowitz · Carlsbad, CAExec · DirectorBryce Paul · Carlsbad, CAExec · DirectorBrett Lyons · Carlsbad, CAExecMalon Wilkus · Falls Church, VADirectorChristian Porwoll · New York, NYDirectorHimanshu Gulati · Falls Church, VADirectorKevin Stanley · Carlsbad, CADirectorSteven M. Shums · TUSTIN, CADirectorGeorge Petrocheilos · New York, NYDirectorJames Moldane · CASTLE PINES, CODirectorJill A. Kendrick · Washington, Washington, D.C.DirectorRoeland J. Smits · Washington, Washington, D.C.DirectorGeorge S. Hall · Washington, Washington, D.C.Exec · DirectorPall J. Eyjolfsson · Luxembourg, LuxembourgDirectorDarren J. Gorman · Luxembourg, LuxembourgExec · DirectorWeston Dinsel · West Chester, PAExecLloyd J. Rodgers · Atlanta, GADirectorThomas S. Harbin Iii · Atlanta, GADirectorHenry Sicignano Iii · VIRGINIA BEACH, VADirectorBadri P. Dasu · Hayward, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗